Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Upcoming patient data

<< Previous

Bullboard Posts

Next >>

Comment by winr88on Feb 19, 2022 12:57pm

267 Views

Post# 34445000

RE:Upcoming patient data

I definitely agree that very positive results for the 180 day and 90 day trials will be reported. I have mixed feelings however how much the share price will increase despite kick A$$ CR results.
I wonder how many in the market are thinking “too good to be true” and are waiting for the other shoe to drop regarding negative health effects or a big correction in trial results to the downside. It doesn’t appear to me any of those negatives will occur. The share price should move substantially upward. We will soon see.

<< Previous

Bullboard Posts

Next >>

BlackBerry’s cost-cutting yields Q1 2024 savings